Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Cash from Investing Activities (2016 - 2025)

Cytokinetics (CYTK) has disclosed Cash from Investing Activities for 16 consecutive years, with $680.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities changed N/A to $680.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $90.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $16.7 million for FY2025, 103.01% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $680.6 million at Cytokinetics, up from $106.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $680.6 million in Q4 2025, with the low at -$651.5 million in Q2 2024.
  • Average Cash from Investing Activities over 5 years is -$2.8 million, with a median of $29.2 million recorded in 2022.
  • The sharpest move saw Cash from Investing Activities tumbled 1118.33% in 2022, then skyrocketed 357.47% in 2023.
  • Over 5 years, Cash from Investing Activities stood at $47.3 million in 2021, then crashed by 38.21% to $29.2 million in 2022, then tumbled by 378.34% to -$81.4 million in 2023, then skyrocketed by 44.66% to -$45.1 million in 2024, then surged by 1610.72% to $680.6 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $680.6 million, $106.0 million, and -$45.1 million for Q4 2025, Q1 2025, and Q3 2024 respectively.